Pergolide as primary therapy for macroprolactinomas
Pituitary, Volume 3, Issue 4, 2000, Pages 251-256.
macroprolactinomaprolactin-secreting pituitary tumorpergolidedopamine agonists
The objective of this study is to determine whether pergolide therapy is an effective modality for the de novo treatment of patients with macroprolactinomas. Twenty-two consecutive patients with macroprolactinomas were included in the study and followed prospectively. These included 16 men and 6 women in whom pregnancy was not of concern....More
Full Text (Upload PDF)
PPT (Upload PPT)